The population mortality benefits of maximizing the number of eligible patients receiving appropriate cardiology treatments in Ireland

Kabir, Z.; Bennett, K.; Shelley, E.; ÜNAL, BELGİN; Critchley, J.; Feely, J.; Capewell, S.

doi:10.1093/qjmed/hcl072

The population mortality benefits of maximizing the number of eligible patients receiving appropriate cardiology treatments in Ireland

Kabir Z., Bennett K., Shelley E., ÜNAL B., Critchley J., Feely J., ...Daha Fazla

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, cilt.99, sa.8, ss.523-530, 2006 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 99 Sayı: 8
Basım Tarihi: 2006
Doi Numarası: 10.1093/qjmed/hcl072
Dergi Adı: QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.523-530
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Dokuz Eylül Üniversitesi Adresli: Hayır

Özet

Background: Coronary heart disease (CHD) mortality rates have been decreasing in many industrialized countries since the 1980s. Up to half this decrease can be attributed to evidence-based medical and surgical cardiology interventions. However, recent studies suggest that modern cardiology treatment uptake levels remain disappointingly low in many patient categories.